Clinical Trial Update: Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating edaravone in patients with amyotrophic lateral sclerosis across Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Edaravone (Edaravone)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Neuromuscular Diseases | Phase 2, Phase 3 | Status: UNKNOWN